Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RepliCel Life Sciences Inc (TSE:RP)
:RP
Holding TSE:RP?
Track your performance easily
RP Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.10
Previous CloseN/A
Volume8.96K
Average Volume (3M)31.20K
Market Cap
$722.32K
Enterprise ValueC$4.23M
Total Cash (Recent Filing)$1.51M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)0.7
Beta0.91
Next Earnings
May 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding72,232,376
10 Day Avg. Volume24,520
30 Day Avg. Volume31,200
Standard Deviation0.25
R-Squared0.00056
Alpha-0.00935
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.08
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap5.86
Enterprise Value/Revenue11.97
Enterprise Value/Gross Profit11.97
Enterprise Value/Ebitda2.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RepliCel Life Sciences News
PremiumCompany Announcements
RepliCel Life Sciences Reschedules Meeting and Board Update
PremiumCompany Announcements
RepliCel Life Sciences Urges Online Access for Shareholders
PremiumCompany Announcements
RepliCel Sells Assets and Licenses Patents for Shareholder GainPremiumCompany Announcements
RepliCel Secures Million Dollar CEO-Backed Loan
PremiumCompany Announcements
RepliCel Proposes Asset Sale to Secure Future RoyaltiesOptions Prices
Currently, No data available
---
Ownership Overview
RP FAQ
What was RepliCel Life Sciences Inc’s price range in the past 12 months?
RepliCel Life Sciences Inc lowest stock price was C$0.01 and its highest was C$0.10 in the past 12 months.
What is RepliCel Life Sciences Inc’s market cap?
RepliCel Life Sciences Inc’s market cap is $722.32K.
When is RepliCel Life Sciences Inc’s upcoming earnings report date?
RepliCel Life Sciences Inc’s upcoming earnings report date is May 06, 2025 which is in 95 days.
How were RepliCel Life Sciences Inc’s earnings last quarter?
RepliCel Life Sciences Inc released its earnings results on Aug 06, 2024. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is RepliCel Life Sciences Inc overvalued?
According to Wall Street analysts RepliCel Life Sciences Inc’s price is currently Overvalued.
Does RepliCel Life Sciences Inc pay dividends?
RepliCel Life Sciences Inc does not currently pay dividends.
What is RepliCel Life Sciences Inc’s EPS estimate?
RepliCel Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RepliCel Life Sciences Inc have?
RepliCel Life Sciences Inc has 72,232,376 shares outstanding.
What happened to RepliCel Life Sciences Inc’s price movement after its last earnings report?
RepliCel Life Sciences Inc reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of RepliCel Life Sciences Inc?
Currently, no hedge funds are holding shares in TSE:RP
---
Company Description
RepliCel Life Sciences Inc
RepliCel Life Sciences, Inc. operates as a regenerative medicine company. The company focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---